Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
Colossal Biosciences
9 followers
Vera Therapeutics
6 followers
Mineralys Therapeutics
3 followers
CG Oncology
2 followers
Generate Biomedicines
5 followers
Gloucester Marine Genomics Institute
1 follower
HydroPeptide LLC
4 followers
BioAge
3 followers
Thermo Fisher Scientific
286 followers
Genentech
226 followers
Gilead Sciences
214 followers
Regeneron
183 followers